EPISODE · Jun 30, 2018 · 9 MIN
Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer
from Listen to The Lancet Oncology · host The Lancet
Bo Jan Noordman joins The Lancet Oncology to discuss the findings from his study of residual disease detection in oesophageal cancer.
Embed this episode
NOW PLAYING
Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer
0:00
9:49
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Listen to The Lancet Oncology?
This episode is 9 minutes long.
When was this Listen to The Lancet Oncology episode published?
This episode was published on June 30, 2018.
Can I download this Listen to The Lancet Oncology episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!